Neuronoff, Inc.

medical devices

About

Neuronoff, Inc. is a medical device company focused on developing neuromodulation technologies to restore and improve organ activity, particularly in the treatment of chronic pain. Based in the United States, the company employs between 11 and 50 people. The flagship product, the Injectrode® Platform, is a minimally invasive, injectable electrode designed to relieve chronic pain without drugs or invasive surgeries. This device is implanted using a simple needle-based procedure, allowing for quick placement and minimal skin puncture. The Injectrode targets peripheral nerve branches, especially in the lumbar lower back, providing a discreet alternative to traditional neuromodulation therapies. Neuronoff's technology has shown safety and effectiveness in successful first-in-human studies, positioning it as a promising option for patients seeking non-pharmacological pain management solutions. The company is led by CEO Manfred Franke, who has extensive experience in neuromodulation research and device development.

Technologies

Gmail Google Apps Microsoft Office 365 Mobile Friendly Wistia Google Tag Manager Google Analytics Squarespace ECommerce WordPress.org Remote

Keywords

neuromodulation drg chronic pain pns stimulation medical equipment manufacturing ultrasound visualization needle-based intervention implant system 510(k) submission reversible device wireless stimulation medical devices low impedance path minimally invasive ultrasound visibility cgmp manufacturing minimal scarring outpatient procedure mri compatibility clinical feasibility healthcare equipment wireless power fluoroscopy visualization non-surgical implantation ultrasound hyperechoic fda approval process neuromodulation therapy b2b patient safety

Location

11000 Cedar Avenue, Cleveland, Ohio, United States, 44106

Related Companies

Companies in the same industry